Mehta, Bella
Kasturi, Shanthini
Teruya-Feldstein, Julie
Horwitz, Steven
Bass, Anne R.
Erkan, Doruk
Article History
Received: 25 September 2017
Accepted: 1 February 2018
First Online: 26 March 2018
Compliance with Ethical Standards
:
: Bella Mehta, MD, Shanthini Kasturi, MD, MS, Julie Teruya-Feldstein, MD, and Anne R. Bass, MD, declare that they have no conflicts of interest. Steven Horwitz, MD, reports receiving grants and personal fees from Celgene, Millennium/Takeda Oncology, Kyowa Hakko Kirin, Seattle Genetics, Forty Seven, and Infinity/Verastem; personal fees from HUYA Bioscience International, Bristol-Myers Squibb, and Mundipharma; and grants from Spectrum Pharmaceuticals, ADC Therapeutics, and Aileron Therapeutics, outside the submitted work. Doruk Erkan, MD, MPH, reports receiving grants from the Lupus Clinical Trial Consortium, the National Heart, Lung, and Blood Institute, HSS Medical Education Academy, EMD Serono, and Xencor; grants and personal fees from GlaxoSmithKline; and personal fees from Ablynx, outside the submitted work.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013.
: Informed consent was waived from all patients for being included in this study.
: Disclosure forms provided by the authors are available with the online version of this article.